Alan Carter - Alterola Biotech Insider

ALTA -- USA Stock  

USD 15.40  14.15  1,132%

Interim President CEO
Dr. Alan H. C. Carter Ph.D., serves as Interim President, Chief Executive Officer of the Company. He was Director of the Company
  CEO Since 2016  Ph.D    
Alan Carter is one of the cofounders, of Alta Floresta Gold Ltd, the Brazilian Gold business that Equitas acquired in April 2016, and as a result, is familiar with all of the Equitas projects in Brazil. He also has 30 years of experience in the minerals exploration industry particularly in South America, and was a cofounder, President & CEO of Magellan Minerals Ltd from 2007 until it was acquired by Anfield Gold in May 2016. During that time Magellan made two significant gold discoveries in Brazil, Cuiu Cuiu and Coringa. He has a Ph.D. in Gold Geochemistry and previously lived and worked in South America mainly with BHP Billiton Ltd. and Rio Tinto. He is currently a director of Peregrine Diamonds Ltd,, and Anfield Gold. He was also a cofounder, former Chief Operating Officer and director of Peregrine Metals Ltd which was sold to Stillwater Mining in 2011. He has a BSc degree in geology from the University of Nottingham and a PhD from the University of Southampton, United Kingdom.

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Stock Performance Indicators

Current Sentiment - ALTA

Alterola Biotech Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Alterola Biotech. What is your sentiment towards investing in Alterola Biotech? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Alterola Biotech and Alphabet. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.